Articles From: 2014/2/7 - LinkedIn down, but China push draws praise to 2014/2/7 - Transition Therapeutics to Hold Conference Call on Second Quarter Fiscal 2014 Financial Results on Wednesday, February 12th, at 4:30 P.M. EST


2014/2/7
By Benjamin Pimentel, MarketWatch SAN FRANCISCO (MarketWatch) -- LinkedIn Corp.
Sign-up for 2014/2/7 - LinkedIn down, but China push draws praise investment picks
2014/2/7
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0926370001&sourceType=1 http://www.ccnmatthews.com/logos/20061010-200romios.jpg TORONTO, ONTARIO --
Sign-up for 2014/2/7 - Romios Doubles Its Holdings in Sheslay Valley, B.C. investment picks
2014/2/7
http://media.marketwire.com/attachments/201107/5424_LeviAndKorsinsky_logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1087619&ProfileId=051205&sourceType=1 NEW YORK, NY --
Sign-up for 2014/2/7 - THORATEC CORPORATION SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Class Action Against THORATEC CORPORATION and Its Board and a Lead Plaintiff Deadline of March 25, 2014 -- THOR investment picks
2014/2/7
ADVISORY, Feb.
Sign-up for 2014/2/7 - OncoMed Pharmaceuticals, Inc. [OMED] to Ring The NASDAQ Stock Market Closing Bell investment picks
2014/2/7
http://media.marketwire.com/attachments/200810/477972_hansen-medical-new-logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1088213&ProfileId=051205&sourceType=1 MOUNTAIN VIEW, CA --
Sign-up for 2014/2/7 - Hansen Medical Announces Fourth Quarter and Fiscal Year 2013 Results Conference Call investment picks
2014/2/7
By Sara Sjolin, MarketWatch LONDON (MarketWatch) -- European stock markets extended gains on Friday as investors digested the latest round of earnings reports and waited for the highly anticipated U.S. nonfarm-payrolls report due in the afternoon.
Sign-up for 2014/2/7 - European stocks climb ahead U.S. nonfarm data investment picks
2014/2/7
Moody’s Corporation (NYSE:MCO) today announced results for the fourth quarter and full-year 2013.
Sign-up for 2014/2/7 - Moody's Corporation Reports Results for Fourth Quarter and Full-Year 2013 investment picks
2014/2/7
HAMILTON, Bermuda , Feb.
Sign-up for 2014/2/7 - OneBeacon Reports $11.58 Book Value Per Share investment picks
2014/2/7
-- Total Revenues Down 2% for Quarter; Up 1% for Year --
Sign-up for 2014/2/7 - Aaron's, Inc. Reports Fourth Quarter and Year End Results investment picks
2014/2/7
Dyax Corp.
Sign-up for 2014/2/7 - Dyax Corp. to Participate in the 2014 Leerink Global Healthcare Conference investment picks
2014/2/7
http://media.marketwire.com/attachments/201004/5033_nxp-one.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1087973&ProfileId=051205&sourceType=1 EINDHOVEN, THE NETHERLANDS --
Sign-up for 2014/2/7 - NXP Semiconductors to Present at Upcoming Investor Events investment picks
2014/2/7
Western Asset High Income Opportunity Fund Inc. (NYSE:HIO) announced today the results of the votes cast at the Fund’s annual meeting of shareholders held on January 31, 2014.
Sign-up for 2014/2/7 - Western Asset High Income Opportunity Fund Inc. Announces Results of Annual Meeting of Shareholders investment picks
2014/2/7
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0926309001&sourceType=1 http://www.ccnmatthews.com/logos/20050705-canarc.gif VANCOUVER, CANADA --
Sign-up for 2014/2/7 - Canarc Announces Retirement of VP Exploration investment picks
2014/2/7
Campbell Soup Company (NYSE:CPB) announced today that Denise Morrison, President and Chief Executive Officer, and Anthony DiSilvestro, Sr.
Sign-up for 2014/2/7 - Campbell Announces the Webcast of Its Presentation at the Consumer Analyst Group of New York Conference investment picks
2014/2/7
Celanese Corporation (NYSE:CE), a global technology and specialty materials company, declared a quarterly dividend of $0.18 per share on its Series A common stock, payable on February 28, 2014.
Sign-up for 2014/2/7 - Celanese Corporation Declares Quarterly Dividend investment picks
2014/2/7
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1088204&ProfileId=051205&sourceType=1 TORONTO, ON --
Sign-up for 2014/2/7 - Easton Pharmaceuticals Signs Letter of Intent / NDA, Enters Into Negotiations With Private B.C. Company Who Has Received Federal License Approval on Medical Marijuana & Closes on Agreement to Engage Leading Legal Consultant investment picks
2014/2/7
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0926484001&sourceType=1 http://media3.marketwire.com/docs/midas200.jpg MCCALL, IDAHO --
Sign-up for 2014/2/7 - Midas Gold Supports Idaho Alpine Skier Erik Fisher for Sochi 2014 Olympic Winter Games investment picks
2014/2/7
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0926478001&sourceType=1 http://www.ccnmatthews.com/logos/20110204-hanlo.JPG VANCOUVER, BRITISH COLUMBIA --
Sign-up for 2014/2/7 - Hanwei Announces Third Quarter Fiscal 2014 Financial Results Conference Call Notification investment picks
2014/2/7
RIDGEFIELD, Conn.
Sign-up for 2014/2/7 - Northern Tier Energy Announces Fourth Quarter Distribution of $0.41 Per Common Unit investment picks
2014/2/7
IXYS Corporation (NASDAQ: IXYS) announced that its Board of Directors has declared a quarterly cash dividend on its common stock of $0.03 per share.
Sign-up for 2014/2/7 - IXYS Declares Quarterly Cash Dividend investment picks
2014/2/7
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will present a corporate update at the 2014 Leerink Global Healthcare Conference on Wednesday, February 12, 2014 at 1:50 p.m. Eastern Time at the Waldorf Astoria Hotel in New York.
Sign-up for 2014/2/7 - Ironwood Pharmaceuticals to Present at Leerink Global Healthcare Conference investment picks
2014/2/7
Resolution Preliminarily Approved with 88.2% Majority WOODLAND HILLS, Calif.
Sign-up for 2014/2/7 - GrowLife Conducts Special Meeting of Stockholders; Approves Authorized Share Increase for Growth investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: 2014/2/7 - LinkedIn down, but China push draws praise to 2014/2/7 - Transition Therapeutics to Hold Conference Call on Second Quarter Fiscal 2014 Financial Results on Wednesday, February 12th, at 4:30 P.M. EST
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity